Pfizer seeks emergency authorization for COVID-19 booster in children ages 5 to 11
Three out of every four children have had coronavirus infections, the CDC reported
Pfizer-BioNTech submitted an application to the U.S. Food and Drug Administration Tuesday, for children ages 5 through 11-years-old to receive the COVID-19 vaccine booster, the company announced.
In a statement, Pfizer said it submitted the application seeking approval under the Emergency Use Authorization after data from a study involving 4,500 children in the U.S., Finland, Poland, and Spain, seeking to determine the "safety, tolerability, and immunogenicity" of the vaccine produced a positive result.-- More...
Read Full Article...
Welcome to CFP’s Comment Section!
The Comment section of online publications is the new front in the ongoing Cancel Culture Battle.
Big Tech and Big Media are gunning for the Conservative Voice—through their Comment Sections.
Canada Free Press wishes to stay in the fight, and we want our fans, followers, commenters there with us.
We ask only that commenters keep it civil, keep it clean.
Thank You for your patience and for staying aboard the CFP ‘Mother Ship’.
READ OUR Commenting Policy